Paratvis

Paratvis is a paediatric oral suspension formulation of paracetamol (acetaminophen) marketed by Vismit Lifesciences. It is a small molecule analgesic and antipyretic used for the management of mild to moderate pain and the reduction of fever in children. The mechanism of action involves the inhibition of prostaglandin synthesis in the central nervous system, primarily through the inhibition of cyclooxygenase (COX) enzymes, although its exact site of action remains a subject of ongoing research. As a generic formulation, it provides a standard therapeutic option for common childhood ailments involving pain and pyrexia.

Brand names

ParatvisParatvis-250Paratvis250Paratvis 250

Other names

ParacetamolAcetaminophenParacetamol Paediatric Oral Suspension